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Abstract
Background: African Americans bear a disproportionate burden of osteoarthritis (OA), with higher prevalence rates,
more severe pain, and more functional limitations. One key barrier to addressing these disparities has been limited
engagement of African Americans in the development and evaluation of behavioral interventions for management
of OA. Pain Coping Skills Training (CST) is a cognitive-behavioral intervention with shown efficacy to improve
OA-related pain and other outcomes. Emerging data indicate pain CST may be a promising intervention for reducing
racial disparities in OA symptom severity. However, there are important gaps in this research, including incorporation of
stakeholder perspectives (e.g. cultural appropriateness, strategies for implementation into clinical practice) and testing
pain CST specifically among African Americans with OA. This study will evaluate the effectiveness of a culturally
enhanced pain CST program among African Americans with OA.
Methods/Design: This is a randomized controlled trial among 248 participants with symptomatic hip or knee OA, with
equal allocation to a pain CST group and a wait list (WL) control group. The pain CST program incorporated feedback
from patients and other stakeholders and involves 11 weekly telephone-based sessions. Outcomes are assessed at
baseline, 12 weeks (primary time point), and 36 weeks (to assess maintenance of treatment effects). The primary outcome
is the Western Ontario and McMaster Universities Osteoarthritis Index, and secondary outcomes include self-efficacy, pain
coping, pain interference, quality of life, depressive symptoms, and global assessment of change. Linear mixed models
will be used to compare the pain CST group to the WL control group and explore whether participant characteristics
are associated with differential improvement in the pain CST program. This research is in compliance with the Helsinki
Declaration and was approved by the Institutional Review Boards of the University of North Carolina at Chapel Hill,
Durham Veterans Affairs Medical Center, East Carolina University, and Duke University Health System.
Discussion: This culturally enhanced pain CST program could have a substantial impact on outcomes for African
Americans with OA and may be a key strategy in the reduction of racial health disparities.
Trial registration: ClinicalTrials.gov, NCT02560922, registered 9/22/2015.
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Background
Osteoarthritis (OA) is a leading cause of pain and disabil-
ity and one of the most commonly diagnosed diseases in
the U.S.; about 27 million adults have symptomatic OA
[1]. The prevalence of OA is expected to double over the
next several decades [2]. In addition to pain and disability,
OA has detrimental effects on depression, anxiety, sleep,
fatigue, physical activity, weight gain, work participation,
and quality of life [3–8]. The rising prevalence of OA and
its significant effects on numerous health outcomes high-
light the need for effective intervention strategies.
African Americans bear a disproportionate burden of
osteoarthritis (OA). A number of studies have shown that
African Americans not only experience higher prevalence
rates of OA than Caucasians, but also more severe pain,
functional limitations, and other adverse outcomes
[9–13]. Despite many years of research highlighting
the disproportionate burden of OA and other pain-
related conditions among African Americans, very lit-
tle has been done to address these disparities [14].
One review noted that key barriers to moving this re-
search forward have included limited engagement by
minority patient groups and a lack of testing of pain
management interventions in these groups, including
African Americans [15].
Pain Coping Skills Training (CST) is a cognitive-
behavioral intervention with shown efficacy to improve
OA-related pain and other outcomes [16–22]. However,
there has been limited work to obtain perspectives on
cultural appropriateness of pain CST among African
Americans with OA. Prior research suggests that pain
CST may be a promising strategy to address racial
disparities in OA-related pain. When compared with
Caucasians, African Americans with OA and other
chronic pain conditions report greater levels of pain
catastrophizing [23, 24], lower perceived ability to cope
with and control pain [25, 26], and greater maladaptive
coping strategies [13, 25, 27, 28]. These coping patterns
can be modified through pain CST [18, 19, 29–31]. In
addition, prior studies indicate that pain coping and
other psychological factors are key contributors to ra-
cial differences in OA-related pain [12, 13]. Based on
this promising research, there is a need for a stronger
evidence base for the effectiveness of pain CST among
African Americans with OA.
This manuscript describes the protocol for a random-
ized controlled trial examining the effectiveness of a cul-
turally enhanced, telephone-based pain CST program
among African Americans with hip or knee OA. The first
objective of this project was to “Engage African American
patients with OA, their support partners, health care pro-
viders, clinic administrators, and public health representa-
tives in a process of evaluating and refining a pain CST
program for culturally appropriate content and dissemin-
ation potential.” The processes and results for this object-
ive are described in the “Pain CST Program Development”
section below. The two aims of the clinical trial are:
Aim #1
Examine the effectiveness of an 11-session, culturally
enhanced, telephone-based pain CST program among
African Americans with hip or knee OA.
We hypothesize that African Americans with symptom-
atic OA who receive a pain CST intervention will have
clinically relevant improvements in pain (Western On-
tario and McMasters Universities Osteoarthritis Index;
WOMAC) and secondary related outcomes at 12 week
follow-up (H1) and 36 week follow-up (H2), compared
with a Waiting List (WL) Control group.
Aim #2
Examine whether individual patient characteristics (par-
ticularly baseline pain catastrophizing score, comorbid-
ity, and duration of OA symptoms) are associated with
differential improvement in the pain CST program.
This aim will involve exploratory analyses of differential
treatment effects according to participant characteristics.
Methods
This study was reviewed and approved by the Institu-
tional Review Boards of the University of North Carolina
at Chapel Hill, Duke University Medical Center, Durham
Veterans Affairs Medical Center (VAMC), and East
Carolina University (all located in the United States).
The funding agency, Patient-Centered Outcomes Re-
search Institute (PCORI), did not have a role in study
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design and will not have a role in the collection, man-
agement, analysis, or interpretation of data.
Study design
The Pain Coping Skills Training for African Americans
with OsteoARTthritis (STAART) study is a parallel-
group design, randomized controlled trial with a planned
sample size of 248 African American participants with
equal allocation to a pain CST group and a (WL) control
group (Fig. 1, Overview of Trial Design). Participants are
patients with hip or knee OA at the University of North
Carolina (UNC) Health Care System or the Durham
VAMC (n = 124 at each site). Randomization is stratified
according to enrollment site and gender to ensure that
the groups are balanced in these respects. The three
measurement time points are baseline, 12 week follow-
up (primary outcome assessment), and 36 week follow-
up (maintenance assessment). Following completion of
the 36 week assessments, participants assigned to the
WL control group will be invited to take part in the CST
program. Participants in both study groups will continue
with their usual medical care for OA during the full
study period.
Participant eligibility criteria
Participants must meet the following criteria for at least
one hip or knee:
 Diagnosis of Hip or Knee OA. This will be identified
from UNC Health Care and Durham VAMC
electronic medical records or based on participant
self-report at screening.
 Current Joint Symptoms. Participants must indicate
having pain, aching, stiffness, or swelling in or
around their hip or knee with OA on most days for
the past month.
Exclusion criteria are shown in Table 1.
Recruitment, enrollment, and randomization
Three general methods of recruitment are being used.
The first involves posting of advertisements at study
sites and the surrounding communities, inviting patients
to self-refer to the study. Second, health care providers
at study sites are able to refer patients to the study team
directly, with patients’ permission. Providers may also
give study brochures to participants. Third, potentially
eligible patients are being actively identified from UNC
and Durham VAMC medical records, based on OA diag-
nosis codes; these patients are mailed letters inviting
participation, followed by a telephone call. All potential
participants are screened for eligibility criteria via tele-
phone. Individuals who meet eligibility criteria and are in-
terested in participating are asked to meet with a study
team member to complete consent, HIPAA authorization,
and baseline assessments. We are using an enhanced in-
formed consent process that includes education about the
research process, participant bill of rights, and perspec-
tives from African Americans who have participated in re-
search. Specifically, participants are mailed the “You’ve
Got the Power!” booklet prior to their enrollment visit and
Enrollment, Baseline Assessment 
(Questionnaires) & Randomization 
(N= 248)
Pain CST
(N= 124)
11 Session 
Intervention
No 
Intervention
No 
Intervention
Wait List  
Control
(N= 124)
No 
Intervention
No 
Intervention
11 Session 
Intervention
12 Week Follow-Up Assessment (Questionnaires)
36 Week Follow-Up Assessment (Questionnaires)
Eligibility Screening
Fig. 1 Overview of Trial Design
Table 1 Exclusion criteria
Diagnosis of gout (in knee or hip), rheumatoid arthritis, fibromyalgia,
or other systemic rheumatic disease
Dementia or other memory loss condition
Active diagnosis of psychosis, serious personality disorder, or current
uncontrolled substance abuse disorder
Total hip/knee replacement surgery, other hip/knee surgery, ACL tear,
or other significant knee/hip injury in the past 6 months
Scheduled for or on a waiting list for joint replacement surgery
Severely impaired hearing or speech (patients must be able to
participate in telephone sessions)
Unable to speak English
Participating in another OA intervention or CST study
Unwilling to be randomized to either study arm
Lower extremity paralysis
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shown the “What You Should Know About Clinical Trials”
video at the beginning of the enrollment visit. Both of these
materials were developed and are distributed by the Na-
tional Medical Association as a part of Project IMPACT –
Increase Minority Participation and Awareness of Clinical
Trials [32]. Following baseline assessments, participants
are given their randomization assignment over the tele-
phone by a study team member not blinded to group as-
signment. Participants randomized to the WL group are
informed that they will begin the CST program after their
follow-up assessments are complete. Randomization is a
stratified block randomization with block sizes <10 main-
tained by the project statistician. The randomization
scheme is contained in the study database and study team
members who are blinded to treatment group do not have
access to this section in the database.
Participants will be withdrawn from the study if they
develop any new health problems or other events that
would either make participation in the study interven-
tion or measures unsafe or confound study outcomes.
These largely mirror study exclusion criteria.
Pain CST program
Pain CST program development
The pain CST program was based on prior clinical trials
among patients with various chronic pain conditions
[18–20, 22]. In addition, previous work with the CST
program incorporated perspectives of African American
men with prostate cancer [33]. Building on that work,
the CST program was refined in a small, single-arm pilot
study among African American Veterans with OA. Then
as part of this project, we worked with a broader group
of stakeholders to further enhance the program with at-
tention to issues of cultural relevance and future dissem-
ination potential. These stakeholders included African
Americans with OA, public health representatives in the
field of arthritis, patient advocates, and health care pro-
viders. During the course of proposal development, we
met with patients and other stakeholders who reviewed
several aspects of the project, including the intervention
content and dissemination plans. In the first phase of
this project, we presented the CST program modules to
a group of African American patients with OA, via tele-
phone, and incorporated their input into the program.
Following presentation of each module, we asked these
stakeholders a series of questions regarding aspects of
the program they liked, components or ideas that were
difficult to understand, ways in which each skill related
or did not relate to their cultural, spiritual, religious or
other values, and barriers they may face to incorporating
each skill into their normal daily lives. We also sought
their input on the intervention handbook. Other mem-
bers of the study stakeholder panel also provided input
on the CST program and handbook. We describe below
the enhancements that have been made to enrich cul-
tural sensitivity for each topic and skill as a result of pre-
vious related work [33] and the early work on this
project.
Overview of the pain CST program
The CST program involves 11 weekly sessions, approxi-
mately 30–45 min each, delivered via telephone by a
trained counselor. Participants are provided with handouts
to facilitate each session, along with an audio recording to
guide progressive muscle relaxation. A counselor provides
instruction in cognitive and behavioral pain coping strat-
egies and also leads participants in guided rehearsals of
these skills. Specific skills are described below. Participants
are asked to engage in home-based practice of the skills to
enhance their application in pain-related situations. During
each session, the counselor reviews participants’ home
practice, including successes and barriers, encourages prob-
lem solving, and works to set goals for application of skills.
CST session topics and skills
Session 1 – Introduction, Rationale for Pain Coping
Skills, Progressive Muscle Relaxation
Introduction. Participants are provided with a brief
overview of the session formats, as well as the CST
participant manual. The importance of regular
practice of the coping skills is emphasized. Feedback
from patient stakeholders contributed to a decision
to frame the CST program as an educational
intervention instead of “treatment” or “therapy.”
Education in the Rationale for CST. Participants are
provided with a brief rationale for the CST intervention,
including components of gate control theory. This helps
participants to understand how their thoughts, feelings,
and behaviors can influence pain, as well as how coping
skills can enhance their ability to control pain.
Progressive Muscle Relaxation. Participants are also
introduced to progressive muscle relaxation in this
session. This technique enhances one’s ability to identify
and decrease tension throughout the body. This skill
involves tensing and relaxing different muscle groups,
from the feet to the forehead, while also maintaining
deep relaxed breathing. After a description of the
technique and a review of its benefits, the CSTcounselor
guides participants through a 15 min relaxation session.
Session 2 – Mini Relaxation Practices and Communi-
cating with Significant Others about Pain and Coping
Mini-Relaxation Practices. Mini-relaxation is a form
of applied relaxation that provides a means to decrease
tension and pain when it is not feasible to do a full
progressive muscle relaxation session. During this
session, the CSTcounselor guides participants through a
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mini-relaxation practice that lasts about 30 s. Partici-
pants are instructed to take a long breath in, exhale
slowly while saying the word “relax” to themselves, and
concentrate on the sensations of relaxation flowing
throughout the body. Participants are then coached on
strategies for applying mini-relaxation practices using
both internal cues (e.g., increase in mood or tension) and
external cues (e.g., before eating a meal). They are also
taught how to use mini-relaxation exercise during
activities of daily living that are potentially painful (e.g.
prolonged standing, transferring from sitting to standing,
and stair climbing).
Communication with Significant Others about
Pain and Coping. One enhancement we made to the
CST program, based on input from our stakeholders
and previous work [19, 33], is increased attention to the
role of significant others (e.g. spouse, family members,
co-workers) in dealing with chronic pain. Specifically,
we added a module that provides guidance in speaking
and listening strategies, as well as expressive versus
decision-making conversations. These are applied to
communicating with significant others about pain.
Following discussion of these topics, the counselor
leads participants in a process of planning effective
expressive and decision-making conversations, using
examples of relevance to them.
Sessions 3 and 4 – Managing Unhelpful Mood Cogni-
tive restructuring (described as “managing unhelpful mood”
for participants in this program), involves teaching partici-
pants to recognize relationships between thoughts, feelings,
and behaviors [34]. Participants are first taught to identify
overly negative, maladaptive thoughts regarding pain and
then to replace those with alternative, more realistic
and helpful coping thoughts that enhance pain control.
Cultural enhancements for this skill have involved
regular encouragement for participants to incorporate
spiritual or other cultural values into thoughts about
pain and pain management.
Session 5 – Activity Pacing In this session, participants
are first taught how to recognize the over-activity cycle,
which is a common approach to dealing with pain. In
this cycle, individuals tend to overdo an activity, require
an extended period of rest or recovery, then overdo the
activity again or choose to avoid the activity altogether.
The over-activity cycle can lead to negative conse-
quences such as increased pain, avoidance of activity,
and increased tension. As an alternative to this maladap-
tive cycle, participants are taught an activity-rest cycling
strategy [35]. Participants are asked to identify activities
in which they tend to overexert themselves, develop a
plan for breaking up those activities into periods of ac-
tivity and rest (i.e., 20 min of housework followed by
10 min of rest), and gradually increase their activity level
and decrease resting periods. One cultural enhancement
for this skill has involved emphasizing the role of rest in
completing tasks, e.g., taking breaks actually can help
individuals to accomplish tasks more easily and effect-
ively. This enhancement was in response to findings of
Campbell and colleagues [33] (and confirmed among
our patient stakeholders) that particularly among African
American men, task completion and contributing to the
larger community is a common value. In addition, in this
session, participants are encouraged to use their commu-
nication skills (Session 2) to explain to others why activity
pacing will help them accomplish tasks.
Session 6 – Pleasant Activities Chronic pain can lead
to social withdrawal and lowered activity levels. To ad-
dress this issue, this session teaches participants strat-
egies for remaining engaged in valued activities. The
counselor asks participants to brainstorm activities they
enjoy or that give them a sense of accomplishment. Par-
ticipants are also given a list of example pleasant activ-
ities based on activities participants have focused on in
prior studies. Participants are asked to set weekly goals
for scheduling pleasant activities they choose, with a
focus on increasing the level and range of these activities
over time. Time is devoted to helping participants de-
velop specific plans for integrating appropriate pleasant
activities into their daily routine, despite time constraints
such as multiple caregiving roles.
Session 7 – Pleasant Imagery and Other Distraction
Techniques Participants are trained in four attention di-
version methods that can enhance pain control: pleasant
imagery, focal point, auditory stimuli, and challenging
mental tasks. Pleasant imagery involves shifting attention
from an unpleasant situation (e.g., increase in pain) to a
pleasant and relaxing scene; this can be used as an ad-
junct to relaxation [36]. Focal point distraction involves
intentionally focusing on a point or object in the environ-
ment for 1–2 min. Similarly, auditory stimuli distraction
involves focusing on a noise in the environment for 1–
2 min. Challenging mental tasks may include counting
backwards in increments of any number or thinking of a
type of food that starts with every letter in the alphabet.
Session 8 – Physical Activity and Osteoarthritis;
Session 9 – Weight Management and Osteoarthritis
The CST counselor works with participants to place pain
CST in the broader context of OA management. Phys-
ical activity and weight management are particularly im-
portant lifestyle strategies for managing OA [37, 38].
Although pain CST is the focus of this intervention, we also
support participants’ engagement in these other lifestyle ap-
proaches, using low literacy materials and intervention
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scripts we developed in other studies [39]. These materials
take a behavioral, goal-setting approach to weight manage-
ment and physical activity. This order was selected stra-
tegically, since each of the pain coping skills will have been
introduced by session 8; this allows the counselor to work
with participants to integrate those skills in their efforts to
change physical activity and dietary patterns. For example,
activity-rest cycling is important for helping patients to
improve overall physical activity without a significant pain
exacerbation. Cognitive restructuring is also important for
helping patients to address unhelpful thoughts that link
pain to these other behaviors. For example, some individ-
uals respond to pain with unhealthy eating patterns; unco-
vering and addressing unhelpful pain-related thoughts is a
key strategy in changing these patterns.
Session 10 – Skills Review and Problem Solving Dif-
ferent coping skills may be particularly helpful for spe-
cific challenging pain-related problem situations (e.g. an
unexpected weekend visit from relatives or having to
take a long plane trip that involves extensive and pro-
longed sitting). To facilitate patients’ ability to deal with
these situations, the CST counselor reviews all of the
skills taught in the program and then teaches partici-
pants a 3-step problem solving technique. This tech-
nique involves 1) describing the situation, 2) identifying
likely difficulties associated with the situation, and 3)
identifying a skill or combination of skills that may be
best suited for the context.
Session 11 – Relapse Prevention and Maintenance
Relapse Prevention. Consistent and continued
practice of pain coping skills is an integral part of
effective pain control. Therefore participants are
introduced to a five-step process to help prevent and
manage potential setbacks. This involves 1) identify-
ing warning signs of a setback, 2) noticing immediate
thoughts and actions during a setback, 3) utilizing a
coping skill, 4) reviewing the situation that lead to a
setback, and 5) making an immediate plan for deal-
ing with setbacks.
Maintenance. In order to encourage continued
practice of pain coping skills, the CST counselor
reviews each skill and their unique benefits. Finally,
the CST counselor helps participants develop an
individualized home program that includes a daily
practice schedule and short- and long-term goals.
CST counselor training and adherence
The counselor received training in the pain CST proto-
col, including role play sessions, by experienced co-
investigators (TS, LC). Counselor training also included
issues related to cultural sensitivity, by a co-investigator
with expertise in this area (LC). Following initial
training, three strategies are being used to ensure adher-
ence to the pain CST program protocol: 1) use of de-
tailed scripts for each module, 2) regular supervision
sessions with co-investigators experienced with the pain
CST program (TS, FJK, LC), and 3) audio-recordings of
a subset of intervention calls which are reviewed by ex-
perienced co-investigators and rated for adherence.
Measures
All study assessments are conducted by trained research
assistants blinded to the participants’ randomization as-
signment. The baseline and 12 week assessments are
conducted in person and the 36 week assessment is con-
ducted via telephone. To facilitate participant retention
and completion of follow up, there is some allowance for
the 12 week assessment to be conducted via telephone
in cases when participants are unable to return to the
study site. Participants are paid $50 for completion of
the baseline assessment, $50 for the 12 week assessment,
and $25 for the 36 week assessment.
Primary outcome
Western Ontario and McMasters Universities Osteoarthritis
Index (WOMAC) pain subscale
The WOMAC pain subscale is one of the most com-
monly used measures of pain among patients with lower
extremity OA. It includes 5 items rated on a Likert scale
of 0 (no symptoms) to 4 (extreme symptoms). The reli-
ability and validity of the WOMAC total score and sub-
scales have been confirmed [40], and this scale has been
widely used in trials of behavioral interventions for pa-
tients with hip and knee OA, confirming its sensitivity
to change in these types of interventions.
Secondary outcomes
WOMAC total score and function subscale
In addition to the pain subscale, the WOMAC includes
stiffness (two items) and function (17 items) subscales.
The WOMAC total score and function subscale are also
common patient-centered outcomes for patients with
lower extremity OA. We are assessing the function sub-
scale separately because of its importance as an outcome
among patients with OA.
Depressive symptoms – patient health questionnaire-8
(PHQ-8)
The PHQ-8 is an 8-item survey derived from the Pri-
mary Care Evaluation of Mental Disorders (PRIME-MD)
diagnostic tool, and consists of items corresponding to
the depression criteria listed in the Diagnostic and Sta-
tistics Manual Fourth Edition (DSM-IV) [41]. Each of
the eight questions is scored as 0 (not at all) to 3 (nearly
every day), so that total scores range from 0 to 24.
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Patient global impression of change
This scale evaluates participants’ perspectives on overall
changes in their joint pain during the study period. This
single-item measure asks participants to describe their
change in pain on a 7-point rating scale with the follow-
ing options: “very much improved,” “much improved,”
“minimally improved,” “no change,” “minimally worse,”
“much worse,” and “very much worse.”
Coping Strategies Questionnaire (CSQ)
This scale includes 48 items that assess 6 cognitive do-
mains (Catastrophizing, Diverting Attention, Ignoring
Sensations, Coping Self-Statements, Reinterpreting Pain
Sensations, Praying-Hoping) and one behavioral domain
(Increasing Behavioral Activities). Each domain includes
six items, and participants rate the frequency of their
use of specific coping strategies on a 7-point Likert scale
from 0 (“Never do that”) to 6 (“Always do that”). The
scale also includes two items that assess participants’
perceptions of the effectiveness of their pain coping
skills, i.e. their subjective ability to control or decrease
their pain, using a similar 7-point Likert scale. The CSQ
is the most commonly used measure of coping among
individuals with chronic pain, and its measurement
properties have been confirmed in patients with a variety
of pain-related conditions [42, 43].
Arthritis self-efficacy scale
This scale includes 8 items asking respondents how cer-
tain they are that they can perform specific activities or
tasks. Items are scored on a Likert Scale (1 = very
uncertain to 10 = very certain). This scale has shown ac-
ceptable construct validity (by its significant associations
with pain, disability, and depression), internal reliability
(alpha = 0.76–0.89), and test-retest reliability (Pearson
r = 0.71–0.85). Higher scores on this scale have been
significantly associated with improved health outcomes
and protection against poor functional outcomes [44, 45].
Health-Related Quality of Life (HRQoL)
The Short-Form 12 Health Survey (SF-12) is a 12-item
validated measure that covers domains of general health,
physical health, work and activity limitations, and emo-
tional health [46]. We are including a measure of
HRQoL based on feedback from our patient stake-
holders, who stressed that OA affects many aspects of
life and recommended that we broadly assess quality of
life in this study.
PROMIS pain interference instrument (Short Form)
The PROMIS Pain Interference (Short Form 6a) instru-
ment measures the self-reported consequences of pain
across aspects of life including social, cognitive, emotional,
physical, and recreational activities; this instrument refers
to the past 7 days [47]. This validated scale has five re-
sponse options, with scores ranging from 1 to 5.
Pain medication use
Participants are asked to bring to their study visits (or
bring to the telephone) all medications (prescription and
non-prescription) they are currently taking for their
arthritis symptoms. For each medication, the study team
records the medication name, medication class, and fre-
quency of taking the medication. We also use a single-
item measure that asks participants whether their overall
pain medication use for OA has increased, decreased, or
stayed about the same since the beginning of the study.
Arthritis self-efficacy for pain communication scale –
patient version
This 7-item instrument assesses patients’ level of confi-
dence in communicating their pain to their partner and
receiving understanding and a helpful response from
their partner [48]. Items are rated on a scale from 10
(“very uncertain”) to 100 (“very certain”).
Starting the conversation: diet (STC)
The STC is an 8-item food frequency instrument that
evaluates dietary assessment and intervention in a clin-
ical setting [49]. Response options for the survey are or-
ganized into three columns; one column indicating the
most healthful dietary practices (scored 0), the 2nd col-
umn indicating less healthful practices (scored 1), and
the 3rd column indicating the least healthful practices
(scored 2).
Brief fear of movement scale
The Brief Fear of Movement Scale is a 6-item scale for
assessing fear of movement in OA [50]. The scale specif-
ically assesses activity avoidance due to pain-related fear
of movement. All items are measured on a 4-point scale
from “strongly agree” to “strongly disagree.”
Pain Catastrophizing Scale (PCS)
This 13-item instrument asks participants to reflect on
past painful experiences and to indicate the degree to
which they experienced each of the thoughts or feelings
when experiencing pain. The PCS includes three sub-
scales – rumination, magnification, and helplessness.
The PCS is a widely used measure of catastrophic think-
ing related to pain [51].
Time missed from work
This is a single item measure asking participants how
many work hours they have missed in the past month
due to their OA pain and other symptoms and related
healthcare visits.
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Demographic and clinical characteristics
Participant characteristics include age, race/ethnicity,
gender, marital status, household financial state (with
low income defined as self-report of “just meeting basic
expenses” or “don’t even have enough to meet basic ex-
penses”), education level, work status, religiosity (Duke
University Religion Index [52]), body mass index, phys-
ical activity (Yale Physical Activity Survey [53]), tobacco
and alcohol use, duration of OA symptoms, general
self-rated health, comorbid illnesses (Self-Administered
Comorbidity Questionnaire [54]), and baseline pain cat-
astrophizing (CSQ subscale [42, 43]).
Participant feedback on CST intervention
At the 12 week follow up assessment, following comple-
tion of the CST intervention, participants in the CST
group will be asked a series of feedback questions related
to specific content (e.g., perceived usefulness and sug-
gestions related to each coping skill) and process (e.g.,
the number and duration of sessions) of the program.
This information will be used by the study team, in con-
junction with the stakeholder panel, to refine the pro-
gram prior to dissemination of deliverables.
Data analyses
The primary and secondary analyses will be conducted
on an intent-to-treat basis. Participants will be analyzed
in the arm to which they were randomized, regardless of
intervention adherence, using all follow-up data. Add-
itional supporting analyses focusing on alternative, more
restrictive analytic cohorts (e.g., as treated) will be con-
sidered as exploratory analyses to provide additional in-
formation about the impact of magnitude of exposure to
the intervention.
Analysis of specific aim #1
We will use a linear mixed model (LMM) that will ac-
count for the correlation between a participant’s repeated
outcome measurements over time. Because of the small
number of time points, we will apply an unstructured co-
variance matrix to take into account the within-patient
correlation between repeated measures. We will estimate
the parameters in the model using the SAS procedure
MIXED (Cary, NC), and will test appropriate parameters
for a difference in mean WOMAC pain scores between
the CST and WL groups at specified time points. A con-
strained longitudinal data model (cLDA) will be fit, in
which baseline WOMAC pain is modeled as a dependent
variable in conjunction with the constraint of a common
baseline mean across the treatment arms [55]. The cLDA
model is comparable to an ANCOVA model, equivalent
when there is no missing data. However, unlike an
ANCOVA, subjects who are missing follow-up measure-
ments are included in the model because baseline is part
of the response vector. For improvement in precision, the
model will also be adjusted for stratification variables of
enrollment site and gender [56]. Similar procedures will
be used for all continuous secondary outcomes. The
secondary outcomes for pain medication use are either di-
chotomous or count type variables. We will fit a general-
ized logit model [57] using the SAS procedure NLMIXED
for these outcomes.
Analysis of specific aim #2
Patients may vary in their response to the CST program;
this variation is known as heterogeneity of treatment ef-
fects (HTE). We have selected three a priori patient
characteristics (baseline pain catastrophizing score, co-
morbidity, and duration of OA symptoms) and will con-
duct a separate descriptive HTE for each. Our general
steps in this secondary analysis will be to add the patient
characteristic main effect, as well as the interaction vari-
ables, to the linear mixed model defined above for pri-
mary analysis. We will examine the parameter estimates
and 95 % CI’s of appropriate parameters to determine
whether there is evidence of HTE. New state-of-the art
modeling methods have taken the exploration of HTE to
the next level, making it possible to explore and identify
multidimensional subgroups exhibiting heterogeneous
treatment effects. We will explore whether the a priori
defined patient characteristics define multidimensional
subgroups that exhibit HTE. We will utilize two differ-
ent analytic strategies for doing so: multivariable logistic
regression (LR) [58, 59] and recursive partitioning (RP)
[60–62]. Our general steps in this secondary analysis will
be: construction of outcome variables; identification of
multidimensional subgroups via LR and RP; and, finally,
examination of treatment effects within the multidimen-
sional subgroups.
Missing data
Our plans for preventing and dealing with missing data
follow the guidelines set forth by the National Research
Council’s Panel on Handling Missing Data in Clinical
Trials. Our goal is to achieve less than 20 % attrition,
which is very reasonable based on our prior and ongoing
OA studies that include large proportions of African
Americans [39, 63, 64]; we will use the same strategies
of reminder calls, reminder letters and flexible schedul-
ing to minimize attrition. Our main analysis technique
for the primary outcomes, general linear mixed models
via maximum likelihood estimation, implicitly accom-
modates missingness when missingness is due either to
treatment, to prior outcome, or to other baseline covari-
ates included in the model, defined as missing at random
[57]. Therefore, inferences will be valid even if we have
differential dropout by intervention arm. However, as a
first sensitivity analysis, we will construct a general,
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multivariate imputation model using all observed pain
measurements, treatment arm, and any covariates pre-
dictive of missingness [65]. If the probability of dropout
is related to the actual missing response (which is unob-
served because it is missing) or to other unobserved
quantities, the missing data due to dropout is considered
missing not at random (MNAR) or nonignorable [66].
We propose as a second sensitivity analysis to explore
MNAR methods, including pattern-mixture models and
the toolkit of methods as presented in O’Kelly and
Ratitch [67].
Sample size
The sample size estimate of n = 124 per arm was based
on the primary research question and the 36-week
follow-up time as that is the most conservative test due
to higher attrition at the 36 week time point versus
12 weeks. Sample size calculations used methods appro-
priate for ANCOVA type analyses [68], which are
equivalent in terms of efficiency to our proposed linear
models in randomized trials [55]. Based on previous
data, we assumed a correlation of 0.6 between baseline
and follow-up WOMAC pain scores, and an SD of 3.9.
With 80 % power, alpha = 0.05, SD = 3.9, rho = 0.60, and
a conservative 20 % attrition rate by 36 weeks, we need
to enroll 124 patients per group to detect a 1.3 point dif-
ference in mean WOMAC pain scores at 36 weeks be-
tween the CST group and the WL control group. Based
on a mean baseline WOMAC pain score of 9.2, this cor-
responds to approximately a 14 % improvement or 0.33
(medium) effect size difference in WOMAC pain, which
is a clinically relevant improvement [69]. Similarly, for
the remaining secondary outcomes, we are powered to
detect a 0.33 effect size difference for the CST arm com-
pared to the WL control group. We have greater than
80 % power to detect a 1.3 point difference in pain
scores between CST and WL at 12 weeks.
Data management and monitoring
Every effort will be made to protect the confidentiality of
participant data. Study data are kept on a secure UNC
computer server that only approved study personnel
have access to. Study tracking data are entered into a se-
cure, password-protected web-based database we have
developed at UNC. Screening and outcome measures
are integrated into this database and are entered in real
time during study assessments. This database provides
customized reports that have important functions for
monitoring a clinical trial. These reports provide updates
on the numbers of participants enrolled, excluded, with-
drew, etc. These reports also facilitate easy checking of
screening and outcomes data so the team can monitor
for unexpected amounts of missing data. Study team
members can generate regular reports, based on a
CONSORT diagram that describes all of these metrics
related to study flow, as well as participant refusal, ineli-
gibility, and withdrawal reasons.
Because this is a study with minimal risk, data moni-
toring is performed by the Principal Investigator and
Institutional Review Board (IRB). This study does not re-
port to a data monitoring committee. All adverse events
are reported to and reviewed by the Principal Investiga-
tor. Any unanticipated problems involving risks to sub-
jects or others are reported to the IRBs per required
timelines. Any important protocol modifications are re-
ported to the UNC and Durham VAMC IRBs as well as
the funding agency, PCORI.
Data access and dissemination
Study contractual agreements encourage openness in
research and making research data available for pur-
poses of replication and reproducibility. As such, the
researchers intend to provide access to project data in a
manner that is consistent with applicable privacy, confi-
dentiality, and other legal requirements. Final results of
the research project will be submitted to ClinicalTrials.gov
as well as the funding agency, PCORI, to ensure that re-
search findings are made available to clinicians, patients,
and the general public. The researchers plan to publish
and present study results, as available, and dissemin-
ation will be conducted to relevant parties via our
stakeholder panel.
For all published manuscripts of this project, we are
following the authorship guidelines set forth by the
International Committee of Medical Journal Editors
(ICMJE). All authors will meet this criteria and anyone
who meets this criteria will be given authorship. Those
who have contributed to the paper but do not meet the
specific criteria set forth by the ICMJE will be included
in the acknowledgements.
Discussion
This study has several important features. First, to our
knowledge, it is the first randomized clinical trial evaluat-
ing the effectiveness of a culturally enhanced, telephone-
based pain coping skills training program for African
Americans with knee or hip OA. Pilot study results sug-
gest that our pain CST program, with cultural tailoring,
may be particularly beneficial for African Americans with
OA, but this larger clinical trial is needed to rigorously
examine its effectiveness. Second, this study takes a
pragmatic approach, including participants who experi-
ence the spectrum of OA symptom severity and incorp-
orating minimal exclusion criteria. This is important
for generalizability of the findings to real-world settings
and a large variety of patients. Third, we are collaborating
with a diverse stakeholder panel, comprised of African
American patients with knee or hip OA, clinicians,
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community partners and organizations that seek to im-
prove health outcomes among African Americans and
other racial/ethnic minority groups, and representatives of
national organizations seeking to improve outcomes for
people with OA. This group has made key contributions
to the development of the pain CST program and study
design and will continue to provide feedback on the inter-
vention and ongoing clinical trial.
We recognize there are limitations to this study. For
ethical reasons, study participants in each group are per-
mitted to receive usual OA treatments during the study
period, and this could impact pain and other outcomes.
However, we are purposefully enrolling patients who are
currently under care for OA in one of two health care
systems. Therefore, we are examining whether the pain
CST program results in improvements in outcomes be-
yond usual OA care. For logistical reasons, we are not
obtaining radiographs from study participants at baseline,
and we therefore cannot characterize participants with re-
spect to radiographic stage of OA. However, we are select-
ing participants on the basis of a diagnosis of OA in the
medical record, along with self-report of physician diagno-
sis of OA.
In summary, results of this study will provide import-
ant information regarding the potential for pain CST
programs to reduce racial disparities in OA-related pain.
If this culturally enhanced CST program is confirmed to
result in clinically meaningful changes among African
Americans with OA, incorporation into clinical settings
could have a substantial impact. This is particularly im-
portant given the high rates of OA and greater symptom
burden among African Americans who suffer from this
condition.
Acknowledgements
The study team expresses gratitude to the stakeholder panel for this project,
without whom this work would not be possible: Ms. Mae Karim, Ms. Sandy
Walker, LPN (Chapel Hill Children’s Clinic), Mr. Ralph Brown, Dr. Yashika Watkins,
PhD, MPH (Movement is Life / University of Illinois at Chicago), Dr. John McKellar,
PhD (Bay Area Pain and Wellness Center, Los Gatos, CA), Dr. Teresa J. Brady, PhD
(Centers for Disease Control and Prevention), Dr. Elaine Hart-Brothers, MD, MPH
(Community Health Coalition), and Ms. Laura C. Marrow (Arthritis Foundation).
The study team also thanks all of the participants taking part in this research.
Funding
Research reported in this manuscript was funded through a Patient-Centered
Outcomes Research Institute (PCORI) Award (AD-1408-19519). The statements
presented in this manuscript are solely the responsibility of the authors and do
not necessarily represent the views of the Patient-Centered Outcomes Research
Institute (PCORI), its Board of Governors, or Methodology Committee.
Availability of data and materials
Not applicable.
Authors’ contributions
LS, SR, BB, AG, CN, and CS contributed to data acquisition and study
coordination. LC, CWC, CJC, FK, EO, TS, ST, and KA contributed to the study
design and protocol (including intervention development and/or enrollment
procedures). CJC contributed to plans for statistical analysis and helped draft
the manuscript. LS and KDA helped draft the manuscript. All authors
reviewed and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Not applicable.
Ethics approval and consent to participate
This research is in compliance with the Helsinki Declaration and was approved
by the Institutional Review Boards of the University of North Carolina at Chapel
Hill, Durham Veterans Affairs Medical Center, East Carolina University, and Duke
University Health System. Written, informed consent will be obtained on all
study participants.
Author details
1Thurston Arthritis Research Center, University of North Carolina at Chapel
Hill, 3300 Thurston Bldg., CB# 7280, Chapel Hill, NC 27599, USA. 2Department
of Medicine, University of North Carolina at Chapel Hill, 125 MacNider Hall
CB# 7005, Chapel Hill, NC 27599, USA. 3Health Services Research and
Development Service, Durham VA Medical Center, Durham, NC, USA.
4Department of Medicine, Duke University Medical Center, Durham, NC, USA.
5Department of Biostatistics and Bioinformatics, Duke University Medical
Center, Durham, NC, USA. 6Department of Psychiatry and Behavioral Science,
Duke University, Durham, NC, USA. 7Department of Psychology, East Carolina
University, Greenville, NC, USA.
Received: 26 July 2016 Accepted: 13 August 2016
References
1. Johnson VL, Hunter DJ. The epidemiology of osteoarthritis. Best Pract Res
Clin Rheumatol. 2014;28:5–15.
2. Centers for Disease C. Prevention. Projected state-specific increases in self-
reported doctor-diagnosed arthritis and arthritis-attributable activity
limitations–United States, 2005-2030. MMWR Morb Mortal Wkly Rep. 2007;
56(17):423–5.
3. Murphy LB, Sacks JJ, Brady TJ, Hootman JM, Chapman DP. Anxiety and
depression among US adults with arthritis: prevalence and correlates.
Arthritis Care Res (Hoboken). 2012;64(7):968–76.
4. Allen KD, Renner JB, DeVellis B, Helmick CG, Jordan JM. Osteoarthritis and
sleep: the Johnston County Osteoarthritis Project. J Rheumatol. 2008;35(6):
1102–7.
5. Theis KA, Murphy L, Hootman JM, Wilkie R. Social participation restriction
among U.S. adults with arthritis: a population-based study using the
International Classification of Functioning, Disability, and Health (ICF).
Arthritis Care Res (Hoboken). 2013;65(7):1059–69.
6. Sharif B, Garner R, Sahmartin C, Flanagan WM, Hennessy D, Marshall DA.
Risk of work loss due to illness or disability in patients with osteoarthritis: a
population-based cohort study. Rheumatology 2016; Epub ahead of print.
7. Centers for Disease Control and Prevention. Arthritis as a potential barrier to
physical activity among adults with heart disease - United States, 2005 and
2007. MMWR Morb Mortal Wkly Rep. 2009;58:165–9.
8. Ackerman IN, Ademi Z, Osborne RH, Liew D. Comparison of health-related
quality of life, work status, and health care utilization and costs according to
hip and knee joint disease severity: a national Australian study. Phys Ther.
2013;93(7):889–99.
9. Dillon CF, Rasch EK, Gu Q, Hirsch R. Prevalence of knee osteoarthritis in the
United States: arthritis data from the Third National Health and Nutrition
Examination Survey 1991-1994. J Rheumatol. 2006;33:2271–9.
10. Jordan JM, Helmick CG, Renner JB, Luta G, Dragomir AD, Woodard J, et al.
Prevalence of knee symptoms and radiographic and symptomatic knee
osteoarthritis in African Americans and Caucasians: the Johnston County
Osteoarthritis Project. J Rheumatol. 2007;31(4):172–80.
11. Allen KD. Racial and ethnic disparities in osteoarthritis phenotypes. Curr
Opin Rheumatol. 2010;22(5):528–32.
12. Allen KD, Helmick CG, Schwartz TA, DeVellis B, Renner JB, Jordan JM. Racial
differences in self-reported pain and function among individuals with
radiographic hip and knee osteoarthritis: the Johnston County Osteoarthritis
Project. Osteoarthr Cartil. 2009;17(9):1132–6.
13. Allen KD, Oddone EZ, Coffman CJ, Keefe FJ, Lindquist JH, Bosworth HB.
Racial differences in osteoarthritis pain and function: potential explanatory
factors. Osteoarthr Cartil. 2010;18:160–7.
Schrubbe et al. BMC Musculoskeletal Disorders  (2016) 17:359 Page 10 of 12
14. Green CR, Anderson KO, Baker TA, Campbell LC, Decker S, Fillingim RB, et al.
The unequal burden of pain: confronting racial and ethnic disparities in
pain. Pain Med. 2003;4(3):277–94.
15. Campbell LC, Robinson K, Meghani SH, Vallerand A, Schatman M, Sonty N.
Challenges and opportunities in pain management disparities research:
implications for clinical practice, advocacy, and policy. J Pain. 2012;13(7):611–9.
16. Carson JW, Keefe FJ, Affleck G, Rumble ME, Caldwell DS, Beaupre PM, et al.
A comparison of conventional pain coping skills training and pain coping
skills training with a maintenance training component: a daily diary analysis
of short- and long-term treatment effects. J Pain. 2006;7(9):615–25.
17. Dixon KE, Keefe FJ, Scipio CD, Perri LM, Abernethy AP. Psychological
interventions for arthritis pain management in adults: a meta-analysis.
Health Psychol. 2007;26(3):241–50.
18. Keefe FJ, Caldwell D, Williams DA, Gil KM, Mitchell D, Robertson C, et al. Pain
coping skills training in the management of osteoarthritic knee pain-II:
follow-up results. Behav Ther. 1990;21(4):435–47.
19. Keefe FJ, Caldwell DS, Baucom D, Salley A, Robinson E, Timmons K, et al.
Spouse-assisted coping skills training in the management of knee pain in
osteoarthritis: long-term follow-up results. Arthritis Care Res. 1999;12(2):101–11.
20. Keefe FJ, Caldwell DS, Williams DA, Gil KM, Mitchell D, Robertson C, et al.
Pain coping skills training in the management of osteoarthritic knee pain: a
comparative study. Behav Ther. 1990;21:49–62.
21. Hurley MV, Walsh NE, Mitchell HL, Pimm TJ, Patel A, Williamson E, et al.
Clinical effectiveness of a rehabilitation program integrating exercise,
self-management, and active coping strategies for chronic knee pain: a
cluster randomized trial. Arthritis Care Res. 2007;57(7):1211–9.
22. Somers TJ, Blumenthal JA, Guilak F, Kraus VB, Schmitt DO, Babyak MA, et al.
Pain coping skills training and lifestyle behavioral weight management in
patients with knee osteoarthritis: a randomized controlled study. Pain.
2012;153(6):1199–209.
23. Edwards RR, Moric M, Husfeldt B, Buvanendran A, Ivankovich O.
Ethnic similarities and differences in the chronic pain experience: a
comparison of african american, Hispanic, and white patients. Pain Med.
2005;6(1):88–98.
24. Ruehlman LS, Karoly P, Newton C. Comparing the experiential and psychosocial
dimensions of chronic pain in African Americans and Caucasians: findings from
a national community sample. Pain Med. 2005;6(1):49–60.
25. Tan G, Jensen MP, Thornby J, Anderson KO. Ethnicity, control appraisal,
coping, and adjustment to chronic pain among black and white Americans.
Pain Med. 2005;6(1):18–28.
26. Allen KD, Bosworth HB, Coffman CJ, Lindquist JH, Sperber N, Weinberger M,
et al. Racial differences in pain coping efficacy in patients with hip and knee
osteoarthritis. Washington: Annual Meeting of the American College of
Rheumatology; 2012.
27. Jones AC, Kwoh CK, Groeneveld PW, Mor M, Geng M, Ibrahim SA. Investigating
racial differences in coping with chronic osteoarthritis pain. J Cross Cult
Gerontol. 2008;23:339–47.
28. Allen KD, Golightly YM, Olsen MK. Pilot study of pain and coping among
patients with osteoarthritis: a daily diary analysis. J Clin Rheumatol.
2006;12(3):118–23.
29. Keefe FJ, Caldwell DS. Cognitive behavioral control of arthritis pain. Adv
Rheumatol. 1997;81(1):277–90.
30. Keefe FJ, Blumenthal JA, Baucom D, Affleck G, Waugh R, Caldwell DS, et al.
Effects of spouse-assisted coping skills training and exercise training in
patients with osteoarthritic knee pain: a randomized controlled study. Pain.
2004;110:539–49.
31. Riddle DL, Keefe FJ, Nay WT, McKee D, Attarian DE, Jensen MP. Pain coping
skills training for patients with elevated pain catastrophizing who are
scheduled for knee arthroplasty: a quasi-experimental study. Arch Phys Med
Rehabil. 2011;92(6):859–65.
32. Project I.M.P.A.C.T. – Increase Minority Participation and Awareness of
Clinical Trials. (n.d.). Retrieved from http://impact.nmanet.org/.
33. Campbell LC, Keefe FJ, Scipio C, McKee DC, Edwards CL, Herman SH, et al.
Facilitating research participation and improving quality of life for
African American prostate cancer survivors and their intimate partners:
a pilot study of telephone-based coping skills training. Cancer.
2006;109(2Suppl):414–24.
34. Beck AT, Rush AJ, Shaw BF, Emery G. Cognitive therapy and depression.
New York: The Guilford Press; 1979.
35. Keefe FJ. Behavior assessment and treatment of chronic pain: current status
and future directions. J Consult Clin Psychol. 1982;1(50):896–911.
36. McCaul D, Malot JM. Distraction and coping with pain. Psychol Bull.
1984;95:516–33.
37. Meneses SR, Goode AP, Nelson AE, Lin J, Jordan JM, Allen KD, et al. Clinical
algorithms to aid osteoarthritis guideline dissemination [published online
ahead of print April 15, 2016]. Osteoarthritis Cartilage. 2016. doi:10.1016/j.
joca.2016.04.004.
38. Messier SP, Mihalko SL, Legault C, Miller GD, Nicklas BJ, DeVita P, et al.
Effects of intensive diet and exercise on knee joint loads, inflammation, and
clinical outcomes among overweight and obese adults with knee
osteoarthritis: the IDEA randomized clinical trial. JAMA. 2013;310(12):1263–73.
39. Allen KD, Bosworth HB, Brock DS, Chapman JG, Chatterjee R, Coffman CJ,
et al. Patient and provider interventions for managing osteoarthritis in
primary care: protocols for two randomized controlled trials. BMC
Musculoskelet Disord. 2012;13(1):60.
40. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation
study of WOMAC: a health status instrument for measuring clinically important
patient relevant outcomes to antirheumatic drug therapy in patients with
osteoarthritis of the hip or knee. J Rheumatol. 1988;15:1833–40.
41. Kroenke K, Strine TW, Spitzer RL, Williams JB, Berry JT, Mokdad AH. The
PHQ-8 as a measure of current depression in the general population.
J Affect Disord. 2009;114(1-3):163–73.
42. Hastie BA, Riley JL, Fillingim RB. Ethnic differences in pain coping: factor
structure of the coping strategies questionnaire and coping strategies
questionnaire-revised. J Pain. 2004;5(6):304–16.
43. Rosenstiel AK, Keefe FJ. The use of coping strategies in chronic low back
pain patients: relationship of patient characteristics and current adjustment.
Pain. 1983;17:33–44.
44. Lorig K, Chastain RL, Ung E, Shoor S, Holman HR. Development and
evaluation of a scale to measure perceived self-efficacy in people with
arthritis. Arthritis Rheum. 1989;32(1):37–44.
45. Sharma L, Cahue S, Song J, Hayes K, Pai YC, Dunlop D. Physical functioning
over three years in knee osteoarthritis: role of psychosocial, local mechanical,
and neuromuscular factors. Arthritis Rheum. 2003;48(12):3359–70.
46. Ware Jr J, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey:
construction of scales and preliminary tests of reliability and validity. Med
Care. 1996;34(3):220–33.
47. Amtmann D, Cook KF, Jensen MP, Chen WH, Choi S, Revicki D, et al.
Development of a PROMIS item bank to measure pain interference. Pain.
2010;150(1):173–82.
48. Porter LS, Keefe FJ, Wellington C, de Williams A. Pain communication in the
context of osteoarthritis: patient and partner self-efficacy for pain
communication and holding back from discussion of pain and arthritis-
related concerns. Clin J Pain. 2008;24(8):662–8.
49. Paxton AE, Strycker LA, Toobert DJ, Ammerman AS, Glasgow RE. Starting
the conversation performance of a brief dietary assessment and
intervention tool for health professionals. Am J Prev Med. 2011;40(1):67–71.
50. Shelby RA, Somers TJ, Keefe FJ, DeVellis BM, Patterson C, Renner JB, et al.
Brief fear of movement scale for osteoarthritis. Arthritis Care Res.
2012;64(6):862–71.
51. Sullivan MJL, Bishop SR, Pivik J. The Pain Catastrophizing Scale:
development and validation. Psychol Assess. 1995;7:524–32.
52. Koenig HG, Bussing A. The Duke University Religion Index (DUREL): a five-item
measure for use in epidemiological studies. Religions. 2010;1:78–85.
53. Dipietro L, Caspersen CJ, Ostfeld AM, Nadel ER. A survey for assessing
physical activity among older adults. Med Sci Sports Exerc. 1993;25:628–42.
54. Sangha O, Stucki G, Liang MH, Fossel AH, Katz JN. The self-administered
comorbidity questionnaire: a new method to assess comorbidity for clinical
and health services research. Arthritis Rheum. 2003;49(2):156–63.
55. Fitzmaurice GM, Laird NM, Ware JH. Applied longitudinal analysis. Hoboken:
Wiley-Interscience; 2004.
56. CPMP. Points to consider on adjustment for baseline covariates. Stat Med.
2004;23:701–9.
57. Hedeker D, Gibbons RD. Longitudinal data analysis. Hoboken: Wiley; 2006.
58. Hayward RA, Krumholz HM, Zulman DM, Timbie JW, Vijan S. Optimizing
statin treatment for primary prevention of coronary artery disease. Ann
Intern Med. 2010;152(2):69–77.
59. Kent DM, Hayward RA, Griffith JL, Vijan S, Beshansky JR, Califf RM, et al. An
independently derived and validated predictive model for selecting
patients with myocardial infarction who are likely to benefit from tissue
plasminogen activator compared with streptokinase. Am J Med.
2002;113(2):104–11.
Schrubbe et al. BMC Musculoskeletal Disorders  (2016) 17:359 Page 11 of 12
60. Kiernan M, Kraemer HC, Winkleby MA, King AC, Taylor CB. Do logistic
regression and signal detection identify different subgroups at risk?
Implications for the design of tailored interventions. Psychol Methods.
2001;6(1):35–48.
61. Owens EB, Hinshaw SP, Kraemer HC, Arnold LE, Abikoff HB, Cantwell DP,
et al. Which treatment for whom for ADHD? Moderators of treatment
response in the MTA. J Consult Clin Psychol. 2003;71(3):540–52.
62. James KE, White RF, Kraemer HC. Repeated split sample validation to assess
logistic regression and recursive partitioning: an application to the
prediction of cognitive impairment. Stat Med. 2005;24(19):3019–35.
63. Allen KD, Yancy Jr WS, Bosworth HB, Coffman CJ, Jeffreys AS, Datta SK, et al.
A combined patient and provider intervention for management of
osteoarthritis in veterans: a randomized clinical trial. Ann Intern Med.
2016;164(2):73–83.
64. Allen KD, Oddone EZ, Coffman CJ, Datta SK, Juntilla KA, Lindquist JH, et al.
Telephone-based self-management of osteoarthritis: a randomized,
controlled trial. Ann Intern Med. 2010;153:570–9.
65. Collins LM, Schafer JL, Kam CM. A comparison of inclusive and restrictive
strategies in modern missing data procedures. Psychol Methods.
2001;6(4):330–51.
66. Molenberghs G, Kenward M. Missing data in clinical studies. Sussex: Wiley; 2007.
67. O’Kelly M, Ratitch B. Clincial trials with missing data. A Guide for
Practitioners. Hoboken, NJ: John Wiley & Sons; 2014.
68. Borm GF, Fransen J, Lemmens W. A simple sample size formula for analysis
of covariance in randomized clinical trials. J Clin Epidemiol. 2007;60(12):1234–8.
69. Angst F, Aeschlimann A, Stucki G. Smallest detectable and minimal clinically
important differences of rehabilitation intervention with their implications
for required sample sizes using WOMAC and SF-36 quality of life
measurement instruments in patients with osteoarthritis of the lower
extremities. Arthritis Rheum. 2001;45(4):384–91.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Schrubbe et al. BMC Musculoskeletal Disorders  (2016) 17:359 Page 12 of 12
